Get started
Author

Qi‐Man Sun

Observed names: QI-MAN SUN, QIMAN SUN, Qi-Man Sun, Qi-man Sun, Qiman Sun
ORCID: 0000-0002-7638-9089
Observed ORCID: 0000-0002-7638-9089
OpenAlex ID: A5103107263
Macrophage-secreted IL-8 induces epithelial-mesenchymal transition in hepatocellular carcinoma cells by activating the JAK2/STAT3/Snail pathway
2014 · XIU-TAO FU, ZHI DAI, et al. · International Journal of Oncology · 230
PDF
Amplification of spatially isolated adenosine pathway by tumor–macrophage interaction induces anti-PD1 resistance in hepatocellular carcinoma
2021 · Jia-Cheng Lu, Peng-Fei Zhang, et al. · Journal of Hematology & Oncology · 162
PDF
Circumventing intratumoral heterogeneity to identify potential therapeutic targets in hepatocellular carcinoma
2017 · Ao Huang, Xin Zhao, et al. · Journal of Hepatology · 118
Tumor‐derived exosomes induce immunosuppressive macrophages to foster intrahepatic cholangiocarcinoma progression
2022 · Chubin Luo, Haoyang Xin, et al. · Hepatology · 109
Distinct PD-L1/PD1 Profiles and Clinical Implications in Intrahepatic Cholangiocarcinoma Patients with Different Risk Factors
2019 · Jia-Cheng Lu, Hai-Ying Zeng, et al. · Theranostics · 72
PDF
New‐onset diabetes after liver transplantation and its impact on complications and patient survival
2015 · Chaoyang Lv, Yao Zhang, et al. · Journal of Diabetes · 69
Plasma MicroRNA, a Potential Biomarker for Acute Rejection After Liver Transplantation
2013 · Jie Hu, Zheng Wang, et al. · Transplantation · 68
Graft Programmed Death Ligand 1 Expression as a Marker for Transplant Rejection Following Anti–Programmed Death 1 Immunotherapy for Recurrent Liver Tumors
2020 · Guo‐Ming Shi, Jiping Wang, et al. · Liver Transplantation · 53
Macro CD5L+ deteriorates CD8+T cells exhaustion and impairs combination of Gemcitabine-Oxaliplatin-Lenvatinib-anti-PD1 therapy in intrahepatic cholangiocarcinoma
2024 · Jia-Cheng Lu, Lei-Lei Wu, et al. · Nature Communications · 52
PDF
microRNA-501-3p suppresses metastasis and progression of hepatocellular carcinoma through targeting LIN7A
2018 · Chubin Luo, Dan Yin, et al. · Cell Death and Disease · 52
CTLA-4 Synergizes With PD1/PD-L1 in the Inhibitory Tumor Microenvironment of Intrahepatic Cholangiocarcinoma
2021 · Xiao-Jun Guo, Jia-Cheng Lu, et al. · Frontiers in Immunology · 47
PDF
The Association between KCNQ1 Gene Polymorphism and Type 2 Diabetes Risk: A Meta-Analysis
2012 · Qiman Sun, Kang Song, et al. · PLoS ONE · 46
PDF
A New Preoperative Prognostic System Combining CRP and CA199 For Patients with Intrahepatic Cholangiocarcinoma
2017 · Bo-Hao Zheng, Liu-Xiao Yang, et al. · Clinical and Translational Gastroenterology · 37
Immune checkpoint inhibitor plus tyrosine kinase inhibitor for unresectable hepatocellular carcinoma in the real world
2021 · Diyang Xie, Qiman Sun, et al. · Annals of Translational Medicine · 34
PDF
The clinical implications and molecular features of intrahepatic cholangiocarcinoma with perineural invasion
2022 · Xian-Long Meng, Jia-Cheng Lu, et al. · Hepatology International · 33
PDF
The mRNA–miRNA–lncRNA Regulatory Network and Factors Associated with Prognosis Prediction of Hepatocellular Carcinoma
2021 · Bo Hu, Xiaolu Ma, et al. · Genomics Proteomics & Bioinformatics · 31
Long non-coding RNA 00607 as a tumor suppressor by modulating NF-κB p65/p53 signaling axis in hepatocellular carcinoma
2018 · Qi-Man Sun, Bo Hu, et al. · Carcinogenesis · 31
Long non-coding RNA00364 represses hepatocellular carcinoma cell proliferation via modulating p-STAT3-IFIT2 signaling axis
2017 · Wei-Guo Tang, Bo Hu, et al. · Oncotarget · 31
PDF
Salvage transhepatic arterial embolization after failed stage I ALPPS in a patient with a huge HCC with chronic liver disease: A case report
2017 · Zheng Wang, Yuanfei Peng, et al. · International Journal of Surgery Case Reports · 29
PDF
Loss of 5-hydroxymethylcytosine induces chemotherapy resistance in hepatocellular carcinoma via the 5-hmC/PCAF/AKT axis
2023 · Xiao-Jun Guo, Xiao-Yong Huang, et al. · Cell Death and Disease · 28
PDF
Characterization of immune infiltration in sarcomatoid hepatocellular carcinoma
2021 · Chubin Luo, Haoyang Xin, et al. · Aging · 26
PDF
Donor liver steatosis: A risk factor for early new‐onset diabetes after liver transplantation
2016 · Mengjuan Xue, Chaoyang Lv, et al. · Journal of Diabetes Investigation · 25
PDF
Tie2-Expressing Monocytes Are Associated with Identification and Prognoses of Hepatitis B Virus Related Hepatocellular Carcinoma after Resection
2015 · Yi-Feng He, Chao-Qun Wang, et al. · PLoS ONE · 24
PDF
Identification of FOS as a Candidate Risk Gene for Liver Cancer by Integrated Bioinformatic Analysis
2020 · Jin-Wu Hu, Guang-Yu Ding, et al. · BioMed Research International · 23
PDF
Tumour-suppressive role of PTPN13 in hepatocellular carcinoma and its clinical significance
2016 · Hao Zhan, Jiahao Jiang, et al. · Tumor Biology · 23
Works count: 56
Citation count: 1,660
H-index: 23
I10-index: 35
Year
Topic
Type